Re: Transfer of ZEN from RBC DI to TFSA
in response to
by
posted on
May 12, 2019 06:48PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Anyone considering transferring Zenith shares to or from anywhere may want to do it ASAP. Given that the P2 trial is now wrapping up and the Superstars with more than 2 yrs of life past where they may no longer have been with us anymore, plus early data on the TNBC trial they are now in prime deal territory. If a deal is not done in the next 1 to 7 months IMO the opportunity will likely not come up again until a P3 trial is complete. My best guess is in the next few months as th P2 data will be disseminated at a number of conferences over that time.
All IMO, dyodd
tada